CAS: 30359-01-4 - (-)-Centrolobol
Formula:C19H24O3
InChI:InChI=1S/C19H24O3/c20-17(10-7-16-8-13-19(22)14-9-16)4-2-1-3-15-5-11-18(21)12-6-15/h5-6,8-9,11-14,17,20-22H,1-4,7,10H2/t17-/m1/s1
InChI key:InChIKey=UYJAYWZGEZOHRU-QGZVFWFLSA-N
SMILES:OC1=CC=C(C=C1)CCCCC(O)CCC2=CC=C(O)C=C2
- Synonyms:
- (αR)-4-Hydroxy-α-[2-(4-hydroxyphenyl)ethyl]benzenepentanol
- Centrolobol, (-)-
- Benzenepentanol, 4-hydroxy-α-[2-(4-hydroxyphenyl)ethyl]-, (R)-
- Benzenepentanol, 4-hydroxy-α-[2-(4-hydroxyphenyl)ethyl]-, (αR)-
- 3-Heptanol, 1,7-bis(p-hydroxyphenyl)-, (R)-(-)-
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Centrolobol REF: TM-TN3621CAS: 30359-01-4 | 98% | 229.00 € | Fri 29 Nov 24 |
 | Centrolobol REF: BP-SBP01879CAS: 30359-01-4 | 95%~99% | To inquire | Tue 03 Dec 24 |
 | Centrolobol REF: 4Z-P-5786CAS: 30359-01-4 | - - - | To inquire | Thu 05 Dec 24 |
 | Centrolobol REF: 3D-FBA35901CAS: 30359-01-4 | Min. 95% | To inquire | Thu 09 Jan 25 |
Centrolobol
CAS:30359-01-4
'(-)-Centrolobol inhibits HSC-T6 cell growth and shows strong cytotoxicity against KB cells in dose-dependent ways.'
Formula:
C19H24O3
Purity:
98%
Color and Shape:
Solid
Molecular weight:
300.39
Ref: TM-TN3621
| 1mg | 229.00 € |
Estimated delivery in United States, on Friday 29 Nov 2024
Ref: BP-SBP01879
| Undefined size | To inquire |
Estimated delivery in United States, on Tuesday 3 Dec 2024
Ref: 4Z-P-5786
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Thursday 5 Dec 2024
Centrolobol
CAS:30359-01-4
Centrolobol is a pharmaceutical preparation that inhibits histone deacetylase activity. It has been shown to …
Formula:
C19H24O3
Purity:
Min. 95%
Molecular weight:
300.4 g/mol
Ref: 3D-FBA35901
| 1mg | To inquire | ||
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Thursday 9 Jan 2025
